GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, APP, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD2, EGFR, ESR1, FABP3, FABP4, FDPS, FUT7, HMGCR, HSD11B1, HSD17B1, MET, PPARA, TRPV1 |
11.8157 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, AKR1B1, ALOX12, ALOX15, APP, AURKB, AXL, CA12, CA2, CA7, CHRM1, CHRM3, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, F3, FABP3, FABP4, FLT3, GPR35, HCAR2, HMGCR, HSD11B1, HSD17B1, HSPA1A, INSR, KDR, MET, PPARA, SMAD3, SRC, TEK, TRPV1, XDH |
11.4048 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALOX15, ALPL, APP, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, FABP3, FABP4, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MMP2, NR3C1, PPARA, RORC, SMAD3, SRC, TEK, TRPV1 |
10.8701 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APP, AXL, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, FABP3, HMGCR, IGF1R, INSR, MMP2, MMP9, NR3C1, PPARA, RORC, SRC, TEK, TRPV1 |
10.4745 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, AKR1B1, ALOX12, ALOX15, APP, AURKB, AXL, CA2, CA7, CDC25B, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, F3, FABP3, FLT3, GPR35, HCAR2, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NR3C1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TRPV1, XDH |
10.083 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, ALOX12, APP, CDC25B, CHRM1, CSNK2A1, CYP1B1, DRD2, DRD3, EGFR, ESR1, F3, FABP3, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, NUAK1, PIM1, SMAD3, SRC, TEK, XDH |
9.96296 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, AKR1B1, ALOX15, APP, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, F3, FLT3, GPR35, HCAR2, HMGCR, HSPA1A, INSR, KDR, MET, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
9.91935 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, AKR1B1, ALOX15, APP, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, F3, FLT3, GPR35, HCAR2, HMGCR, HSPA1A, INSR, KDR, MET, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
9.90695 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, AKR1B1, ALOX12, ALOX15, APP, AURKB, AXL, CA2, CA7, CDC25B, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, F3, FABP3, FABP4, FLT3, GPR35, HCAR2, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NR3C1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TRPV1, XDH |
9.71691 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, ESR1, FDPS, HMGCR, HSD11B1, HSD17B1 |
9.6136 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, ALOX15, ALPL, APP, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, FABP3, FABP4, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, NR3C1, PPARA, RORC, SMAD3, SRC, TEK, TRPV1 |
9.51527 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, APP, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, FLT3, NR3C1, RORC, SRC, TEK, TRPV1 |
9.22015 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, APP, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, F3, FABP3, FABP4, FDPS, FLT3, FUT7, HMGCR, HSD11B1, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NR3C1, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TRPV1, XDH |
9.22015 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, APP, CA2, CA9, CSNK2A1, CYP1A2, DRD1, DRD5, EGFR, ESR1, FABP3, FLT3, IGF1R, INSR, MMP2, NR3C1, PPARA, SMAD3, SRC, TEK, TRPV1 |
8.75515 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, APP, AXL, CHRM1, CHRM3, CHRM5, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, F3, FABP4, HMGCR, IGF1R, INSR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, RORC, SMAD3, SRC, TEK, TRPV1 |
8.44352 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, ALOX15, APP, AURKB, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, DUSP3, EGFR, ESR1, F3, FLT3, GPR35, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PTPN1, SRC, TEK, XDH |
8.30035 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, ALOX12, ALOX15, APP, AXL, CA2, CA7, CHRM1, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, F3, GPR35, HCAR2, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, PPARA, PTPN1, SMAD3, SRC, TEK, TRPV1 |
8.15509 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, AKR1B1, ALOX15, APP, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, F3, FLT3, GPR35, HCAR2, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, XDH |
8.05645 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, AKR1B1, ALOX15, APP, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, F3, FLT3, GPR35, HCAR2, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, XDH |
7.91207 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALOX15, ALPL, APP, AXL, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD5, EGFR, ESR1, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, NR3C1, RORC, SMAD3, SRC, TRPV1 |
7.8586 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, ALOX12, APP, CHRM1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
7.80211 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, ALOX12, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, HCAR2, HMGCR, HSPA1A, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, SMAD3, SRC, TEK, TRPV1, XDH |
7.78213 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, ALOX12, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, HCAR2, HMGCR, HSPA1A, IGF1R, KDR, MET, MMP9, PIM1, PTPN1, SMAD3, SRC, TEK, TRPV1, XDH |
7.68287 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, FABP3, FDPS, FUT7, HMGCR, HSPA1A, PIM1, PPARA, XDH |
7.38464 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ALOX15, APP, CDC25B, CHRM5, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, FABP3, FABP4, FLT3, HMGCR, IGF1R, INSR, KDR, MMP9, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, XDH |
7.28711 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, APP, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, FABP3, FABP4, FDPS, FLT3, FUT7, HMGCR, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, NR3C1, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, XDH |
7.2871 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX12, ALOX15, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD2, EGFR, FABP3, FABP4, FDPS, FUT7, HMGCR, MET, PPARA |
7.2871 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ALOX15, APP, CDC25B, CHRM5, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, FABP3, FABP4, FLT3, HMGCR, IGF1R, INSR, KDR, MMP9, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, XDH |
7.24498 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, ALOX15, APP, AXL, CYP1B1, DRD2, EGFR, F3, FLT3, GPR35, HMGCR, HSPA1A, INSR, KDR, MET, PTPN1, SRC, TEK, XDH |
7.22017 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALOX15, ALPL, APP, AXL, CYP1A1, CYP1B1, DRD1, DRD5, EGFR, ESR1, FABP4, FLT3, IGF1R, INSR, KDR, MMP2, NR3C1, RORC, SMAD3, SRC, TRPV1 |
7.22017 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, AKR1B1, ALOX12, APP, AXL, CA12, CA2, CA7, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, FABP3, FABP4, FLT3, GPR35, INSR, MET, SMAD3, SRC, TRPV1 |
7.1301 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, ALOX12, APP, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
7.1277 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, ALOX12, CDC25B, CHRM1, CSNK2A1, DRD2, DRD3, EGFR, ESR1, F3, FLT3, HMGCR, IGF1R, INSR, KDR, MMP2, MMP9, PIM1, TEK |
7.10634 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, ALOX12, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, HCAR2, HMGCR, HSPA1A, IGF1R, KDR, MMP9, PIM1, PTPN1, SMAD3, SRC, TEK, TRPV1, XDH |
7.10634 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, ALOX12, ALOX15, APP, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, DRD3, FDPS, HMGCR |
7.07987 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, AKR1B1, ALOX15, APP, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, EGFR, F3, FLT3, GPR35, HMGCR, HSPA1A, INSR, KDR, MET, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
7.07987 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
7.07987 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, APP, AURKB, CDC25B, CSNK2A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, F3, FABP4, FLT3, GPR35, HMGCR, HSPA1A, IGF1R, INSR, MET, MMP9, NUAK1, PIM1, PPARA, PTPN1, SMAD3, SRC, TEK, TRPV1, XDH |
6.97795 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APP, CYP1A1, CYP1B1, DRD1, DRD5, EGFR, ESR1, FLT3, NR3C1, RORC, SRC, TRPV1 |
6.92938 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, APP, AURKB, CSNK2A1, CYP1B1, CYP2D6, DRD2, DRD3, DRD5, DUSP3, ESR1, FABP4, GPR35, HMGCR, IGF1R, MET, MMP9, PIM1, PPARA, PTPN1, SRC |
6.84712 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, ALOX12, APP, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
6.81082 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CHRM5, CYP1A1, DRD3, FABP3, FDPS, FLT3, HCAR2, HMGCR, PPARA, RORC, SRC, TEK |
6.789 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, ALOX12, APP, CA12, CA2, CA7, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, FABP3, FABP4, GPR35, INSR, MET, SMAD3, TRPV1 |
6.74532 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, ALOX12, AURKB, AXL, CSNK2A1, EGFR, HMGCR, HSPA1A, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, SMAD3, SRC, TEK |
6.69895 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, EGFR, FDPS, HMGCR |
6.67058 |
[BP] GO:0007197 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
6.59698 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, ALOX15, APP, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, EGFR, FABP4, KDR, MMP9, SRC |
6.59027 |
[BP] GO:0007200 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD5, ESR1 |
6.57036 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, ALOX12, AURKB, AXL, CSNK2A1, EGFR, HMGCR, HSPA1A, IGF1R, KDR, MET, MMP9, PIM1, PTPN1, SMAD3, SRC, TEK |
6.50328 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, FABP3, FLT3, INSR, NR3C1, PPARA, SRC, TEK, TRPV1 |
6.49108 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALOX15, ALPL, APP, AURKB, AXL, CDC25B, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, FDPS, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTPN1, SRC, TEK, XDH |
6.43303 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALOX15, ALPL, APP, AURKB, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD5, EGFR, ESR1, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, NR3C1, NUAK1, PTPN1, RORC, SMAD3, SRC, TRPV1 |
6.39208 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, ALOX12, APP, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
6.33895 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, PIM1, SRC, TEK |
6.26194 |
[BP] GO:0007207 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
6.18991 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD2, EGFR, ESR1, HCAR2, HMGCR, HSD11B1, HSD17B1 |
6.11634 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
6.07456 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALOX15, ALPL, APP, AURKB, AXL, CDC25B, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, FDPS, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTPN1, SRC, TEK, XDH |
6.05437 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, ALOX12, APP, CYP19A1, DRD2, DUSP3, EGFR, ESR1, F3, FABP4, HMGCR, HSPA1A, IGF1R, MET, MMP2, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, XDH |
6.00076 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, DRD2, DRD3, EGFR, F3, INSR, MET, SRC, TEK, XDH |
5.98959 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ALOX15, APP, AURKB, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, F3, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NR3C1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TRPV1, XDH |
5.98959 |
[BP] GO:0003018 |
None
|
ADORA1, CHRM1, CHRM3, DRD1, DRD5, EGFR, HMGCR, SRC, TEK |
5.9678 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, EGFR, FDPS |
5.95355 |
[BP] GO:0007188 |
None
|
ADORA1, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5 |
5.95355 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX12, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, FABP3, FABP4, GPR35, HMGCR, HSPA1A, IGF1R, KDR, MET, MMP9, NR3C1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TRPV1, XDH |
5.93217 |
[BP] GO:0030335 |
positive regulation of cell migration
|
ALOX12, APP, DRD1, EGFR, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
5.92269 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ALOX12, ALOX15, CYP19A1, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, HMGCR, HSPA1A, IGF1R, MET, MMP9, PPARA, PTPN1, SMAD3, SRC, TEK, XDH |
5.91893 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, AXL, CA9, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, FABP3, HMGCR, KDR, NR3C1, SRC, TRPV1 |
5.91893 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, ALOX12, AURKB, AXL, CSNK2A1, EGFR, HMGCR, HSPA1A, IGF1R, KDR, MMP9, PIM1, PTPN1, SMAD3, SRC, TEK |
5.85736 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX12, ALOX15, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, FABP3, FABP4, GPR35, HCAR2, HMGCR, HSPA1A, IGF1R, KDR, MET, MMP9, NR3C1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TRPV1, XDH |
5.83231 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ALOX15, APP, CDC25B, DRD1, DRD2, DRD5, EGFR, FABP3, FLT3, HMGCR, INSR, KDR, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
5.83231 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ALOX15, APP, CDC25B, DRD1, DRD2, DRD5, EGFR, FABP3, FLT3, HMGCR, INSR, KDR, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
5.83231 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APP, AXL, CYP1B1, DRD1, DRD5, EGFR, ESR1, IGF1R, INSR, MMP2, MMP9, NR3C1, RORC, SRC, TRPV1 |
5.79513 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, APP, AURKB, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, F3, FABP4, FLT3, HMGCR, HSPA1A, IGF1R, INSR, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, XDH |
5.79293 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, ALOX15, ALPL, APP, AURKB, AXL, CA2, CA9, CDC25B, CHRM1, CHRM2, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, FABP4, FLT3, FUT7, HMGCR, HSD11B1, INSR, KDR, MET, MMP2, MMP9, PIM1, PPARA, RORC, SMAD3, SRC, TEK |
5.78993 |
[BP] GO:2000147 |
positive regulation of cell motility
|
ALOX12, APP, DRD1, EGFR, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
5.78993 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APP, DRD1, DRD2, DRD3, DRD5, EGFR, FABP3, FLT3, IGF1R, INSR, MMP2, PPARA, SRC, TEK, TRPV1 |
5.75791 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, AKR1B1, APP, AXL, CA1, CA2, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, F3, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, MET, MMP2, MMP9, NR3C1, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TRPV1 |
5.75791 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, ALOX15, ALPL, APP, AXL, CA2, CHRM1, CHRM2, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, FLT3, HSD11B1, INSR, KDR, MMP9, PIM1, PPARA, RORC, SMAD3, SRC, TEK |
5.74514 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, APP, AURKB, CA2, CYP1A1, DRD1, DRD2, DRD3, EGFR, HMGCR, HSPA1A, MMP2, PPARA, SMAD3, SRC, TEK, TRPV1 |
5.69956 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ALOX15, APP, AURKB, CDC25B, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, F3, FABP3, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NR3C1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TRPV1, XDH |
5.69843 |
[BP] GO:0007193 |
None
|
ADORA1, CHRM1, CHRM2, CHRM3, CHRM5, DRD2, DRD3 |
5.69339 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
ALOX12, APP, DRD1, EGFR, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
5.67937 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, AKR1B1, ALOX15, APP, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, EGFR, F3, FABP4, FLT3, GPR35, HMGCR, HSPA1A, INSR, KDR, MET, MMP2, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
5.65871 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, ALOX15, APP, AXL, CA2, CA7, CHRM1, CYP19A1, DRD1, DRD2, DRD3, EGFR, GPR35, HCAR2, HMGCR, HSPA1A, INSR, MMP9, PPARA, PTPN1, SMAD3, SRC, TRPV1 |
5.64789 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, CA2, CA7, DRD1, DRD2, DRD3, EGFR, HCAR2, HMGCR, KDR, SRC, TRPV1 |
5.64789 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, AKR1B1, ALOX12, ALOX15, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, F3, FABP4, FLT3, GPR35, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP2, MMP9, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, XDH |
5.63573 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, ALOX12, CYP19A1, DRD1, DRD2, DRD3, EGFR, ESR1, F3, FABP4, HMGCR, KDR, MET, PPARA, SMAD3, TEK |
5.62688 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, GPR35, HMGCR, HSPA1A, IGF1R, MET, MMP9, PTPN1, SMAD3, SRC, XDH |
5.60918 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, ALPL, APP, AURKB, AXL, CA2, CA9, CHRM2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, F3, FABP3, FABP4, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, NR3C1, NUAK1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TRPV1 |
5.59749 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, GPR35, HMGCR, HSPA1A, IGF1R, MET, MMP9, PTPN1, SMAD3, SRC, XDH |
5.59409 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, APP, AURKB, AXL, CDC25B, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, F3, FABP3, FABP4, FDPS, FLT3, FUT7, HMGCR, HSD11B1, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NR3C1, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TRPV1, XDH |
5.57331 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, ALOX15, CYP1A1, DRD2, DRD5, EGFR, PPARA, SMAD3 |
5.56949 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ALOX15, APP, AURKB, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, F3, FABP3, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NR3C1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TRPV1, XDH |
5.56619 |
[BP] GO:0040017 |
positive regulation of locomotion
|
ALOX12, APP, DRD1, EGFR, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
5.5471 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, AXL, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, HMGCR, KDR, SRC |
5.51548 |
[BP] GO:0007187 |
None
|
ADORA1, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5 |
5.50419 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, APP, AURKB, AXL, CDC25B, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, F3, FABP3, FABP4, FDPS, FLT3, FUT7, HMGCR, HSD11B1, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NR3C1, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TRPV1, XDH |
5.50115 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD11B1, HSD17B1 |
5.47025 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
5.45688 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
5.40346 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APP, DRD1, DRD2, DRD3, DRD5, EGFR, FABP3, FLT3, IGF1R, INSR, MMP2, PPARA, SRC, TEK, TRPV1 |
5.40175 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, DRD3, FABP3, PPARA, TRPV1 |
5.35965 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
5.35762 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ALOX15, APP, DRD2, EGFR, FLT3, HMGCR, INSR, KDR, PTPN1, SRC, TEK, XDH |
5.35632 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ALOX15, APP, DRD2, DUSP3, EGFR, FLT3, HMGCR, IGF1R, INSR, KDR, PTPN1, SRC, TEK, XDH |
5.34549 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
ALOX12, ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
5.21775 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, EGFR, HSPA1A |
5.2026 |
[BP] GO:0050890 |
None
|
ADORA1, APP, CHRM1, DRD1, DRD2, DRD3, DRD5, EGFR, HMGCR, INSR |
5.17623 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ALOX12, APP, AXL, CA2, CHRM1, CHRM2, CHRM3, CYP1B1, DRD2, DRD3, EGFR, ESR1, F3, GPR35, HCAR2, HMGCR, HSPA1A, INSR, KDR, MET, MMP9, PIM1, SMAD3, SRC, TEK, TRPV1, XDH |
5.17151 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ALOX15, APP, DRD2, DUSP3, EGFR, HMGCR, KDR, PTPN1, SRC, TEK |
5.15251 |
[BP] GO:0003013 |
None
|
ADORA1, CHRM1, CHRM3, DRD1, DRD5, EGFR, HMGCR, SRC, TEK |
5.14379 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ALOX12, APP, AXL, CA2, CHRM3, CYP1B1, DRD2, DRD3, EGFR, F3, HCAR2, HMGCR, HSPA1A, KDR, MET, MMP9, PIM1, SMAD3, SRC, TEK, TRPV1 |
5.14014 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, CA2, CA7, DRD1, DRD2, DRD3, KDR, SRC, TRPV1 |
5.09561 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
ADORA1, ALOX12, CYP19A1, DRD1, DRD2, DRD3, HMGCR, PPARA, SMAD3, TEK |
5.09313 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX12, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
5.09313 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, AKR1B1, ALOX15, APP, AURKB, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, F3, FLT3, GPR35, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, XDH |
5.07326 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX12, ALOX15, APP, AURKB, AXL, CA1, CA12, CA2, CA7, CA9, CDC25B, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, F3, FABP3, FABP4, FDPS, FLT3, GPR35, HCAR2, HMGCR, HSD11B1, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NR3C1, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TRPV1, XDH |
5.01617 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, APP, AURKB, AXL, CDC25B, CHRM1, CHRM3, CSNK2A1, CYP1A1, CYP1A2, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, F3, FLT3, FUT7, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, SMAD3, SRC, TEK, XDH |
4.93174 |
[BP] GO:0050801 |
ion homeostasis
|
APP, CA12, CA2, CA7, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, FABP3, GPR35, SMAD3, TRPV1 |
4.91747 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX12, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
4.90357 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, ALOX15, APP, AURKB, CA9, CDC25B, CHRM5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, F3, FABP3, FABP4, FDPS, FLT3, HCAR2, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NR3C1, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TRPV1, XDH |
4.90029 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, APP, DRD1, DRD5, EGFR, ESR1, FLT3, IGF1R, INSR, MMP2, NR3C1, SMAD3, SRC, TRPV1 |
4.82008 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, APP, CA2, CA7, DRD1, DRD2, DRD3, DRD5, EGFR |
4.82008 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, APP, CA2, CA7, DRD1, DRD2, DRD3, DRD5, EGFR |
4.82008 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD17B1 |
4.80705 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, CDC25B, CSNK2A1, DRD1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
4.70596 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ALOX15, APP, CDC25B, DRD1, DRD2, DUSP3, EGFR, FABP4, FLT3, HMGCR, IGF1R, INSR, KDR, MMP9, PPARA, PTPN1, SRC, TEK, XDH |
4.62388 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, PTPN1, SRC, TEK |
4.61813 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ALOX15, APP, AURKB, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, F3, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NR3C1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, XDH |
4.59237 |
[BP] GO:0001963 |
None
|
DRD1, DRD2, DRD3, DRD5 |
4.58164 |
[BP] GO:0008306 |
None
|
APP, DRD1, DRD2, DRD3, DRD5, HMGCR |
4.58164 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
ADORA1, AKR1B1, ALOX12, DRD1, DRD2, MET, TRPV1 |
4.56133 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, EGFR, ESR1, FABP3, FLT3, NR3C1, RORC, SRC |
4.56117 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, APP, AXL, CA2, CHRM1, CYP19A1, DRD1, DRD2, DRD3, EGFR, HCAR2, INSR, SMAD3, SRC, TRPV1 |
4.56007 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ALOX15, APP, CDC25B, DRD1, DRD2, DUSP3, EGFR, FABP4, FLT3, HMGCR, IGF1R, INSR, KDR, MMP9, PTPN1, SRC, TEK, XDH |
4.53529 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, APP, CA2, CA7, DRD1, DRD2, EGFR |
4.49957 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
DRD2, DRD3, DUSP3, ESR1, HMGCR, HSPA1A, IGF1R, MET, MMP9, PTPN1, SRC, XDH |
4.48062 |
[BP] GO:0007213 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
4.48062 |
[BP] GO:0044057 |
None
|
ADORA1, ADORA3, CHRM1, CHRM2, CHRM3, DRD2, DRD3, EGFR, GPR35, HCAR2, SMAD3, TRPV1 |
4.46618 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, APP, AURKB, CSNK2A1, CYP2D6, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, FABP4, HCAR2, HMGCR, HSPA1A, IGF1R, KDR, MET, MMP9, NR3C1, PPARA, PTPN1, RORC, SMAD3, SRC, TRPV1, XDH |
4.44518 |
[BP] GO:0097746 |
None
|
ADORA1, CHRM1, CHRM3, DRD1, DRD5, EGFR, HMGCR |
4.44186 |
[BP] GO:0035296 |
None
|
ADORA1, CHRM1, CHRM3, DRD1, DRD5, EGFR, HMGCR |
4.44186 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DRD1, DRD2, DRD3, EGFR, INSR, SMAD3, TRPV1 |
4.43455 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, FDPS, HMGCR, HSD11B1, HSD17B1 |
4.40176 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, ALOX15, APP, AURKB, CA9, CDC25B, CHRM5, CSNK2A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, F3, FABP3, FABP4, FDPS, FLT3, HCAR2, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NR3C1, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TRPV1, XDH |
4.36251 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
APP, CA12, CA2, CA7, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, GPR35, SMAD3, TRPV1 |
4.34703 |
[BP] GO:0045776 |
None
|
ADORA1, DRD2, DRD3, DRD5, PPARA |
4.34334 |
[BP] GO:0050880 |
None
|
ADORA1, CHRM1, CHRM3, DRD1, DRD5, EGFR, HMGCR |
4.28083 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, DRD3, FABP3, PPARA, TRPV1 |
4.27516 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, CHRM1, CHRM3, CHRM5, CYP1A1, EGFR, ESR1, FLT3, MET, PIM1, SRC, TEK |
4.26995 |
[BP] GO:0035150 |
None
|
ADORA1, CHRM1, CHRM3, DRD1, DRD5, EGFR, HMGCR |
4.26776 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, HMGCR, HSD11B1, HSD17B1, XDH |
4.25422 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
ALOX15, APP, DRD2, EGFR, HMGCR, KDR, SRC, TEK |
4.24987 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, ALOX15, APP, CDC25B, DRD1, DRD2, DUSP3, EGFR, FABP4, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MMP9, NUAK1, PTPN1, SRC, TEK, XDH |
4.22491 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, ALOX12, ALOX15, CSNK2A1, CYP19A1, CYP1A1, CYP3A4, FDPS, HMGCR, HSD11B1, HSD17B1 |
4.22247 |
[BP] GO:0007612 |
None
|
APP, DRD1, DRD2, DRD3, DRD5, HMGCR, INSR |
4.21327 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
ALOX15, APP, AURKB, AXL, DRD2, DRD3, ESR1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, SMAD3, SRC, TEK |
4.21036 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, ALOX15, APP, CDC25B, CSNK2A1, DRD2, EGFR, ESR1, F3, FLT3, HMGCR, HSPA1A, INSR, KDR, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
4.20088 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, PTPN1, SMAD3, SRC, TEK |
4.14696 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, ESR1, FLT3, HSD11B1, INSR, KDR, PPARA, SMAD3, SRC, TEK |
4.14434 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, INSR, KDR, SRC |
4.13574 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CYP1B1, DRD1, EGFR, KDR, NR3C1, SRC, TRPV1 |
4.13161 |
[BP] GO:0048511 |
rhythmic process
|
AXL, CSNK2A1, DRD2, DRD3, EGFR, ESR1, PPARA, RORC, SRC |
4.10813 |
[BP] GO:0045787 |
positive regulation of cell cycle
|
APP, AURKB, CDC25B, CYP1A1, DRD2, DRD3, DUSP3, EGFR, INSR, SRC |
4.10411 |
[BP] GO:0008542 |
None
|
APP, DRD1, DRD2, DRD3, HMGCR |
4.09969 |
[BP] GO:2001300 |
lipoxin metabolic process
|
ALOX12, ALOX15, ALOX5 |
4.05094 |
[BP] GO:0016098 |
monoterpenoid metabolic process
|
CYP1A2, CYP2D6, CYP3A4 |
4.05094 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ALOX15, APP, CDC25B, DRD2, EGFR, FLT3, HMGCR, INSR, KDR, MMP9, PTPN1, SRC, TEK, XDH |
3.99686 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX12, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP3, PPARA |
3.9732 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, ALOX15, APP, CDC25B, DRD2, EGFR, ESR1, F3, FLT3, HMGCR, HSPA1A, INSR, KDR, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
3.94707 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, EGFR, F3, INSR, MET, SRC, TEK |
3.93161 |
[BP] GO:0095500 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
3.90409 |
[BP] GO:1903831 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
3.90409 |
[BP] GO:0007632 |
None
|
APP, DRD1, DRD2, DRD3, HMGCR |
3.90371 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APP, DRD1, DRD5, EGFR, IGF1R, INSR, MMP2, SRC, TRPV1 |
3.88456 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX12, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
3.88456 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, DRD1, DRD2, DRD3, EGFR, HCAR2 |
3.86285 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, APP, CDC25B, DRD2, DUSP3, EGFR, FABP4, FLT3, HMGCR, IGF1R, INSR, PTPN1, SRC, TEK |
3.83655 |
[BP] GO:0009820 |
alkaloid metabolic process
|
CYP1A2, CYP2D6, CYP3A4 |
3.83655 |
[BP] GO:0051701 |
interaction with host
|
AXL, EGFR, HSPA1A, INSR, MET, SMAD3, SRC |
3.83655 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
ALOX12, ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
3.83511 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
ALOX12, CYP1A1, CYP1A2, CYP1B1, DRD5, EGFR |
3.78833 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ALOX15, APP, CDC25B, DRD2, EGFR, FLT3, HMGCR, INSR, KDR, MMP9, PTPN1, SRC, TEK, XDH |
3.78833 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, ALOX15, APP, AURKB, CA9, CDC25B, CHRM5, CSNK2A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, F3, FABP3, FABP4, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NR3C1, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TRPV1, XDH |
3.7801 |
[BP] GO:1901617 |
organic hydroxy compound biosynthetic process
|
AKR1B1, ALOX12, ALOX15, CYP19A1, CYP3A4, FDPS, HMGCR |
3.77535 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, APP, AURKB, CDC25B, DRD2, DRD5, EGFR, ESR1, ESR2, F3, FLT3, HSPA1A, INSR, MET, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
3.7667 |
[BP] GO:0007611 |
None
|
APP, DRD1, DRD2, DRD3, DRD5, EGFR, HMGCR, INSR |
3.75885 |
[BP] GO:0010038 |
response to metal ion
|
ALOX15, APP, CA2, CYP1A1, CYP1A2, DRD2, EGFR, FABP4, MMP9 |
3.74745 |
[BP] GO:0055080 |
cation homeostasis
|
APP, CA2, CA7, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, GPR35, SMAD3, TRPV1 |
3.72301 |
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADORA1, ADORA3, APP, CA2, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5, ESR1, GPR35, HCAR2, INSR, SRC |
3.72301 |
[BP] GO:0001975 |
None
|
DRD1, DRD2, DRD3, DRD5 |
3.7181 |
[BP] GO:0072507 |
divalent inorganic cation homeostasis
|
APP, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, GPR35, SMAD3, TRPV1 |
3.70129 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, CDC25B, CSNK2A1, DRD1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
3.68429 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, APP, AURKB, CDC25B, DRD2, DUSP3, EGFR, FABP4, FLT3, HMGCR, IGF1R, INSR, PTPN1, SRC, TEK |
3.67513 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, EGFR, MMP9, SRC |
3.67065 |
[BP] GO:0051940 |
None
|
DRD1, DRD2, DRD3 |
3.67061 |
[BP] GO:0051584 |
None
|
DRD1, DRD2, DRD3 |
3.67061 |
[BP] GO:0007271 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
3.66393 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD17B1 |
3.64928 |
[BP] GO:0071363 |
cellular response to growth factor stimulus
|
APP, EGFR, INSR, KDR, NR3C1, SMAD3, SRC, TRPV1 |
3.64928 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APP, DRD1, DRD5, EGFR, IGF1R, INSR, MMP2, SRC, TRPV1 |
3.62562 |
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
ADORA1, ALOX15, APP, CDC25B, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, ESR1, F3, FABP4, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, XDH |
3.59054 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, NR3C1, PIM1, PPARA, RORC, SRC |
3.58819 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
APP, AURKB, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, FABP3, IGF1R, INSR, KDR, MET, NR3C1, PPARA, RORC, SMAD3, SRC, TRPV1 |
3.55943 |
[BP] GO:0050789 |
regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX12, ALOX15, APP, AURKB, AXL, CA1, CA2, CA7, CA9, CDC25B, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, F3, FABP3, FABP4, FDPS, FLT3, GPR35, HCAR2, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NR3C1, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TRPV1, XDH |
3.55943 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, DRD1, DRD2, DRD5 |
3.55799 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, DUSP3, EGFR, FLT3, HMGCR, IGF1R, INSR, PTPN1, SRC |
3.55799 |
[BP] GO:0001503 |
ossification
|
ALOX15, ALPL, EGFR, MMP2, MMP9, TEK |
3.55799 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, RORC |
3.55799 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, APP, AXL, CA1, CSNK2A1, DRD2, EGFR, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, MMP2, MMP9, PTPN1, SMAD3, SRC, TEK, TRPV1 |
3.53438 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CYP19A1, DRD2, EGFR, ESR1, FABP4, HSPA1A, MMP2, PPARA, PTPN1, SMAD3, SRC, TEK |
3.51204 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, APP, CDC25B, DRD2, DUSP3, EGFR, FABP4, FLT3, HMGCR, IGF1R, INSR, PTPN1, SRC |
3.50333 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, CYP1A1, DRD2, MMP2, PPARA, SMAD3, SRC, TEK |
3.50056 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, CSNK2A1, DRD1, DRD2, DRD3 |
3.50056 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, FABP3, FABP4, FUT7, HSPA1A, MMP1, MMP2, MMP9, SRC, XDH |
3.49309 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APP, FABP3, IGF1R, INSR, PPARA, SRC, TEK, TRPV1 |
3.48537 |
[BP] GO:0050794 |
regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX12, ALOX15, APP, AURKB, AXL, CA1, CA2, CA7, CA9, CDC25B, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, F3, FABP3, FABP4, FLT3, GPR35, HCAR2, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NR3C1, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TRPV1, XDH |
3.47954 |
[BP] GO:0001659 |
None
|
ADORA1, DRD1, DRD2, TRPV1 |
3.45693 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, CYP1A1, DRD2, MMP2, PPARA, SMAD3, SRC, TEK |
3.41482 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, APP, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD5, EGFR, HSPA1A, MMP2, MMP9, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, TRPV1 |
3.41212 |
[BP] GO:0030003 |
cellular cation homeostasis
|
APP, CA2, CA7, DRD1, DRD2, DRD3, DRD5, ESR1, GPR35, SMAD3, TRPV1 |
3.40971 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, CA2, CA7, DRD2 |
3.40802 |
[BP] GO:0007191 |
None
|
DRD1, DRD3, DRD5 |
3.39651 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.39651 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, APP, CA2, CHRM1, DRD2, DRD3, EGFR, HCAR2, HMGCR, PTPN1, SMAD3, SRC |
3.39184 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4 |
3.39011 |
[BP] GO:0003008 |
None
|
ADORA1, AKR1B1, APP, CHRM1, CHRM3, CHRM5, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, HMGCR, INSR, SRC, TEK, TRPV1 |
3.36799 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
CHRM5, FABP3, FLT3, SRC, TEK |
3.34781 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, AXL, CYP1B1, EGFR, HSPA1A, MMP9, SRC |
3.34475 |
[BP] GO:0006873 |
cellular ion homeostasis
|
APP, CA2, CA7, DRD1, DRD2, DRD3, DRD5, ESR1, GPR35, SMAD3, TRPV1 |
3.32311 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
APP, AURKB, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, HSPA1A, IGF1R, INSR, MET, NR3C1, PPARA, PTPN1, RORC, SMAD3, SRC |
3.32051 |
[BP] GO:0070848 |
response to growth factor
|
APP, EGFR, INSR, KDR, NR3C1, SMAD3, SRC, TRPV1 |
3.29641 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, NR3C1, PPARA, RORC, SRC |
3.27721 |
[BP] GO:0021885 |
forebrain cell migration
|
AXL, DRD1, DRD2, EGFR |
3.26826 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, HMGCR, MMP2, MMP9 |
3.244 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, APP, AURKB, CDC25B, DRD2, DRD5, EGFR, ESR1, F3, FLT3, HSPA1A, INSR, PTPN1, SMAD3, SRC, TEK, XDH |
3.23941 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, APP, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, F3, FABP3, FABP4, FDPS, FLT3, FUT7, GPR35, HCAR2, HMGCR, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NR3C1, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TRPV1, XDH |
3.22454 |
[BP] GO:0042060 |
None
|
ALOX15, DRD5, EGFR, PPARA, SMAD3 |
3.22196 |
[BP] GO:0006874 |
cellular calcium ion homeostasis
|
APP, DRD1, DRD2, DRD3, DRD5, ESR1, GPR35, SMAD3, TRPV1 |
3.21934 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, DRD2, DRD3, EGFR, HCAR2, SRC, TRPV1 |
3.21167 |
[BP] GO:0007212 |
None
|
DRD1, DRD2, DRD3, DRD5 |
3.18448 |
[BP] GO:0032467 |
None
|
AURKB, CDC25B, DRD2, DRD3 |
3.18448 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, CYP1A1, DRD2, MMP2, PPARA, SMAD3, SRC, TEK |
3.18358 |
[BP] GO:0007268 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5 |
3.17703 |
[BP] GO:0098916 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5 |
3.17703 |
[BP] GO:0070989 |
oxidative demethylation
|
CYP1A2, CYP2D6, CYP3A4 |
3.17562 |
[BP] GO:0014075 |
None
|
DRD1, DRD2, DRD3, DRD5 |
3.14877 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
APP, AURKB, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, FABP3, IGF1R, INSR, MET, NR3C1, PPARA, RORC, SMAD3, SRC, TRPV1 |
3.14664 |
[BP] GO:0055074 |
calcium ion homeostasis
|
APP, DRD1, DRD2, DRD3, DRD5, ESR1, GPR35, SMAD3, TRPV1 |
3.13161 |
[BP] GO:0010638 |
positive regulation of organelle organization
|
ALOX15, AURKB, DRD3, HSPA1A, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
3.12254 |
[BP] GO:0007154 |
None
|
ADORA1, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5, ESR2, TEK, TRPV1 |
3.12254 |
[BP] GO:0099536 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5 |
3.11493 |
[BP] GO:0099537 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5 |
3.11493 |
[BP] GO:0051128 |
regulation of cellular component organization
|
ALOX12, ALOX15, APP, AURKB, AXL, CSNK2A1, DRD2, DRD3, EGFR, ESR1, ESR2, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, PTPN1, SMAD3, SRC, TEK |
3.10268 |
[BP] GO:0032872 |
regulation of stress-activated MAPK cascade
|
APP, DUSP3, EGFR, HMGCR, IGF1R, PTPN1, XDH |
3.09962 |
[BP] GO:0072503 |
cellular divalent inorganic cation homeostasis
|
APP, DRD1, DRD2, DRD3, DRD5, ESR1, GPR35, SMAD3, TRPV1 |
3.0975 |
[BP] GO:0070302 |
regulation of stress-activated protein kinase signaling cascade
|
APP, DUSP3, EGFR, HMGCR, IGF1R, PTPN1, XDH |
3.08927 |
[BP] GO:0050878 |
regulation of body fluid levels
|
ADORA1, AKR1B1, ALOX12, CHRM1, CHRM3, DRD2, F3, MET, XDH |
3.08357 |
[BP] GO:0060134 |
None
|
DRD1, DRD2, DRD3 |
3.08357 |
[BP] GO:0060158 |
None
|
DRD1, DRD2, DRD5 |
3.08357 |
[BP] GO:0046960 |
None
|
DRD1, DRD5 |
3.07766 |
[BP] GO:2001301 |
lipoxin biosynthetic process
|
ALOX12, ALOX15 |
3.07766 |
[BP] GO:2001302 |
lipoxin A4 metabolic process
|
ALOX12, ALOX15 |
3.07766 |
[BP] GO:2001303 |
lipoxin A4 biosynthetic process
|
ALOX12, ALOX15 |
3.07766 |
[BP] GO:0045931 |
positive regulation of mitotic cell cycle
|
APP, CDC25B, CYP1A1, DRD3, DUSP3, INSR |
3.07766 |
[BP] GO:0007267 |
None
|
ADORA1, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5, ESR2, TEK |
3.07434 |
[BP] GO:0051246 |
regulation of protein metabolic process
|
ADORA1, ALOX15, APP, CDC25B, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, ESR1, F3, FABP4, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, XDH |
3.07176 |
[BP] GO:0060255 |
regulation of macromolecule metabolic process
|
ACHE, ADORA1, ADORA3, ALOX15, APP, AURKB, CA9, CDC25B, CHRM5, CSNK2A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, F3, FABP4, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NR3C1, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TRPV1, XDH |
3.05969 |
[BP] GO:0009410 |
None
|
DRD1, DRD2, DRD3, DRD5, EGFR, NR3C1 |
3.05014 |
[BP] GO:1904407 |
positive regulation of nitric oxide metabolic process
|
EGFR, INSR, SMAD3, TRPV1 |
3.05014 |
[BP] GO:0045429 |
positive regulation of nitric oxide biosynthetic process
|
EGFR, INSR, SMAD3, TRPV1 |
3.05014 |
[BP] GO:0050877 |
None
|
ADORA1, APP, CHRM1, CHRM5, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, HMGCR, INSR, TRPV1 |
3.02783 |
[BP] GO:0071248 |
cellular response to metal ion
|
ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9 |
3.02033 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, HMGCR, HSPA1A, IGF1R, MET, MMP9, PTPN1, SMAD3, SRC, XDH |
3.00645 |
[BP] GO:0008217 |
None
|
ADORA1, DRD2, DRD3, DRD5, PPARA, SMAD3 |
3.00627 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
3.00492 |
[BP] GO:0051580 |
None
|
DRD1, DRD2, DRD3 |
3.00492 |
[BP] GO:0046903 |
None
|
ALOX5, APP, AXL, CA2, CA9, CHRM1, CHRM3, CHRM5, DRD2, DRD3, HSPA1A, MMP9, TRPV1, XDH |
2.98637 |
[BP] GO:0006584 |
None
|
AKR1B1, DRD1, DRD2, DRD3 |
2.97941 |
[BP] GO:0009712 |
None
|
AKR1B1, DRD1, DRD2, DRD3 |
2.97941 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, SRC, TEK |
2.97941 |
[BP] GO:2000379 |
positive regulation of reactive oxygen species metabolic process
|
EGFR, INSR, SMAD3, TRPV1, XDH |
2.95832 |
[BP] GO:0040008 |
regulation of growth
|
ALOX12, APP, CSNK2A1, DRD2, DRD3, EGFR, ESR2, HSPA1A, INSR, PIM1, SMAD3 |
2.92983 |
[BP] GO:0055082 |
cellular chemical homeostasis
|
APP, CA2, CA7, DRD1, DRD2, DRD3, DRD5, ESR1, GPR35, SMAD3, TRPV1 |
2.92983 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, ALOX15, APP, CDC25B, DRD2, EGFR, FLT3, HMGCR, INSR, KDR, MMP9, PTPN1, SRC, TEK, XDH |
2.92165 |
[BP] GO:0097366 |
None
|
DRD1, DRD2, DRD3, DRD5 |
2.90991 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ADORA1, ADORA3, ALOX15, APP, AURKB, CA9, CDC25B, CSNK2A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, F3, FABP3, FABP4, FLT3, HMGCR, HSPA1A, IGF1R, INSR, KDR, MET, MMP9, NR3C1, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TRPV1, XDH |
2.90911 |
[BP] GO:0007346 |
regulation of mitotic cell cycle
|
APP, AURKB, CDC25B, CYP1A1, DRD3, DUSP3, EGFR, HSPA1A, INSR, PIM1, SMAD3 |
2.89934 |
[BP] GO:0007610 |
None
|
APP, DRD1, DRD2, DRD3, DRD5, EGFR, HMGCR, INSR, PPARA, TRPV1 |
2.89551 |
[BP] GO:0055065 |
metal ion homeostasis
|
APP, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, GPR35, SMAD3, TRPV1 |
2.86369 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.84489 |
[BP] GO:0032225 |
None
|
DRD1, DRD2, DRD3 |
2.84489 |
[BP] GO:0019372 |
lipoxygenase pathway
|
ALOX12, ALOX15, ALOX5 |
2.84489 |
[BP] GO:0050793 |
regulation of developmental process
|
ALOX12, APP, AXL, CA2, CYP1B1, DRD2, DRD3, EGFR, ESR1, F3, HMGCR, INSR, KDR, NUAK1, PIM1, PPARA, RORC, SMAD3, SRC, TEK, TRPV1, XDH |
2.82094 |
[BP] GO:0044283 |
None
|
AKR1B1, ALOX12, ALOX15, ALOX5, CYP19A1, CYP1A1, CYP3A4, FDPS, HMGCR |
2.81839 |
[BP] GO:0006939 |
None
|
CHRM3, DRD1, DRD2, TRPV1 |
2.81085 |
[BP] GO:0042752 |
None
|
ADORA1, DRD2, DRD3, PPARA, RORC |
2.80338 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
APP, AURKB, CSNK2A1, CYP2D6, DRD2, DRD3, DUSP3, ESR1, ESR2, FABP4, HMGCR, HSPA1A, IGF1R, MET, MMP9, NR3C1, PPARA, PTPN1, RORC, SMAD3, SRC, TRPV1, XDH |
2.77937 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, NR3C1, PPARA, RORC, SRC |
2.76538 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APP, AXL, CYP1B1, EGFR, HSPA1A, MMP9, SRC |
2.76013 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, CYP2D6, MET, MMP9, PPARA, SMAD3, SRC |
2.76013 |
[BP] GO:0051828 |
entry into other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.75303 |
[BP] GO:0051806 |
entry into cell of other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.75303 |
[BP] GO:0030260 |
entry into host cell
|
AXL, EGFR, HSPA1A, MET, SRC |
2.75303 |
[BP] GO:0044409 |
entry into host
|
AXL, EGFR, HSPA1A, MET, SRC |
2.75303 |
[BP] GO:2000377 |
regulation of reactive oxygen species metabolic process
|
CYP1B1, EGFR, INSR, SMAD3, TRPV1, XDH |
2.74446 |
[BP] GO:0031348 |
negative regulation of defense response
|
ADORA1, CYP19A1, DRD2, PPARA, SMAD3, TEK |
2.71692 |
[BP] GO:0019226 |
None
|
CHRM5, DRD1, DRD5 |
2.70614 |
[BP] GO:0051172 |
None
|
APP, AURKB, CSNK2A1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, FABP4, HMGCR, HSPA1A, IGF1R, MMP9, NR3C1, PPARA, PTPN1, RORC, SMAD3, SRC, TRPV1, XDH |
2.70614 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9 |
2.70614 |
[BP] GO:0023052 |
None
|
ADORA1, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5, ESR2, TEK |
2.7036 |
[BP] GO:1903428 |
positive regulation of reactive oxygen species biosynthetic process
|
EGFR, INSR, SMAD3, TRPV1 |
2.69538 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, EGFR, MMP9, SRC |
2.68206 |
[BP] GO:0009822 |
alkaloid catabolic process
|
CYP2D6, CYP3A4 |
2.67856 |
[BP] GO:0060160 |
None
|
DRD2, DRD3 |
2.67856 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.67856 |
[BP] GO:0045187 |
None
|
ADORA1, DRD2, DRD3 |
2.64928 |
[BP] GO:0007617 |
None
|
APP, DRD1, DRD5 |
2.64928 |
[BP] GO:0051893 |
regulation of focal adhesion assembly
|
KDR, SMAD3, SRC, TEK |
2.64471 |
[BP] GO:0090109 |
regulation of cell-substrate junction assembly
|
KDR, SMAD3, SRC, TEK |
2.64471 |
[BP] GO:1901654 |
None
|
AKR1B1, CA9, CSNK2A1, EGFR, NR3C1, SRC |
2.64063 |
[BP] GO:0032922 |
None
|
DRD2, DRD3, PPARA, RORC |
2.61636 |
[BP] GO:0048148 |
None
|
DRD1, DRD2, DRD3 |
2.58854 |
[BP] GO:0035813 |
None
|
ADORA1, DRD2, DRD3 |
2.58854 |
[BP] GO:0090066 |
None
|
ADORA1, ALOX15, CHRM1, CHRM3, DRD1, DRD5, EGFR, HMGCR |
2.57119 |
[BP] GO:0032787 |
None
|
ALOX12, ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP3, PPARA |
2.57119 |
[BP] GO:1903391 |
regulation of adherens junction organization
|
KDR, SMAD3, SRC, TEK |
2.56246 |
[BP] GO:0045428 |
regulation of nitric oxide biosynthetic process
|
EGFR, INSR, SMAD3, TRPV1 |
2.56246 |
[BP] GO:0019538 |
protein metabolic process
|
ACHE, ALPL, APP, AURKB, AXL, CDC25B, CHRM1, CHRM3, CSNK2A1, DRD1, DUSP3, EGFR, ESR1, F3, FLT3, FUT7, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, SMAD3, SRC, TEK |
2.54988 |
[BP] GO:0090068 |
positive regulation of cell cycle process
|
APP, AURKB, CDC25B, CYP1A1, DRD2, DRD3, INSR |
2.53828 |
[BP] GO:0006875 |
cellular metal ion homeostasis
|
APP, DRD1, DRD2, DRD3, DRD5, ESR1, GPR35, SMAD3, TRPV1 |
2.53694 |
[BP] GO:0042749 |
None
|
ADORA1, DRD2, DRD3 |
2.53548 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.53548 |
[BP] GO:0051726 |
regulation of cell cycle
|
APP, AURKB, CDC25B, CSNK2A1, CYP1A1, DRD2, DRD3, DUSP3, EGFR, HSPA1A, INSR, PIM1, SMAD3, SRC |
2.53534 |
[BP] GO:0044089 |
positive regulation of cellular component biogenesis
|
ALOX15, ESR1, HSPA1A, KDR, MET, MMP1, SMAD3, SRC, TEK |
2.5353 |
[BP] GO:0050728 |
negative regulation of inflammatory response
|
ADORA1, CYP19A1, PPARA, SMAD3, TEK |
2.52746 |
[BP] GO:0006066 |
None
|
AKR1B1, AKR1B10, APP, CYP1B1, CYP3A4, FDPS, HMGCR |
2.52676 |
[BP] GO:0043269 |
regulation of ion transport
|
ADORA1, APP, CA2, CA7, CHRM1, DRD1, DRD2, DRD3, GPR35, MMP9 |
2.52546 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, DRD1, DRD2, EGFR |
2.51903 |
[BP] GO:0070988 |
demethylation
|
CYP1A1, CYP1A2, CYP2D6, CYP3A4 |
2.51903 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, CSNK2A1, DRD1, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
2.51282 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.48226 |
[BP] GO:0043086 |
negative regulation of catalytic activity
|
APP, CSNK2A1, DRD2, DRD3, DRD5, DUSP3, FABP4, HMGCR, IGF1R, MMP9, PTPN1, SRC |
2.48183 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
2.4752 |
[BP] GO:0009416 |
response to light stimulus
|
APP, AURKB, DRD1, DRD2, DRD3, EGFR, HMGCR |
2.45143 |
[BP] GO:1903522 |
None
|
ADORA1, ADORA3, CHRM1, CHRM2, CHRM3, DRD2, EGFR |
2.45143 |
[BP] GO:0050727 |
regulation of inflammatory response
|
ADORA1, CYP19A1, EGFR, ESR1, FABP4, PPARA, SMAD3, TEK |
2.4467 |
[BP] GO:0071900 |
regulation of protein serine/threonine kinase activity
|
ADORA1, DUSP3, EGFR, FLT3, HMGCR, IGF1R, INSR, PTPN1, SRC |
2.43703 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, APP, AXL, CDC25B, CYP19A1, CYP1A1, DRD1, DRD5, EGFR, ESR1, INSR, MMP2, MMP9, SRC |
2.43491 |
[BP] GO:0044062 |
None
|
ADORA1, DRD2, DRD3 |
2.43483 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.43483 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.43276 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.43276 |
[BP] GO:0035556 |
intracellular signal transduction
|
AKR1B1, AXL, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, IGF1R, INSR, KDR, MET, NUAK1, PTPN1, SRC, TEK |
2.42882 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, PPARA, SRC, TEK |
2.41767 |
[BP] GO:0051894 |
None
|
KDR, SMAD3, TEK |
2.39363 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1 |
2.39363 |
[BP] GO:0008299 |
None
|
CYP1A1, FDPS, HMGCR |
2.39363 |
[BP] GO:0061900 |
None
|
APP, EGFR, TRPV1 |
2.39363 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.39363 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, SRC, TEK |
2.39026 |
[BP] GO:0022600 |
None
|
CHRM1, CHRM3, CHRM5, DRD3 |
2.38632 |
[BP] GO:0006940 |
None
|
ADORA1, CHRM1, CHRM2, CHRM3 |
2.38632 |
[BP] GO:2000026 |
regulation of multicellular organismal development
|
ALOX12, APP, AXL, CA2, CYP1B1, DRD2, DRD3, EGFR, ESR1, F3, HMGCR, INSR, KDR, PIM1, SMAD3, SRC, TEK, XDH |
2.36068 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, MET, MMP9, PPARA, SRC |
2.36062 |
[BP] GO:0046486 |
glycerolipid metabolic process
|
ACHE, ALOX15, CSNK2A1, DRD2, EGFR, FABP3, FABP4, MET |
2.3509 |
[BP] GO:0043281 |
regulation of cysteine-type endopeptidase activity involved in apoptotic process
|
CSNK2A1, F3, MMP9, SMAD3, SRC, XDH |
2.3509 |
[BP] GO:0016125 |
None
|
APP, CYP19A1, CYP1B1, FDPS, HMGCR |
2.34914 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, HMGCR, MMP2, MMP9 |
2.34914 |
[BP] GO:0050927 |
None
|
F3, KDR, SMAD3 |
2.34875 |
[BP] GO:0044267 |
cellular protein metabolic process
|
ALPL, APP, AURKB, AXL, CDC25B, CHRM1, CHRM3, CSNK2A1, DRD1, DUSP3, EGFR, ESR1, FLT3, FUT7, IGF1R, INSR, KDR, MET, MMP1, MMP2, NUAK1, PIM1, PTPN1, SMAD3, SRC, TEK |
2.3436 |
[BP] GO:0015908 |
None
|
DRD2, DRD3, FABP3, PPARA |
2.34329 |
[BP] GO:0051223 |
None
|
ACHE, APP, CHRM1, DRD2, DRD3, EGFR, HCAR2, HMGCR, PTPN1, SMAD3, SRC |
2.33976 |
[BP] GO:0080135 |
regulation of cellular response to stress
|
APP, DUSP3, EGFR, HMGCR, HSPA1A, IGF1R, MET, NUAK1, PTPN1, XDH |
2.33678 |
[BP] GO:0019725 |
cellular homeostasis
|
APP, CA2, CA7, DRD1, DRD2, DRD3, DRD5, ESR1, GPR35, SMAD3, TRPV1 |
2.3239 |
[BP] GO:0032465 |
None
|
AURKB, CDC25B, DRD2, DRD3 |
2.32372 |
[BP] GO:0006706 |
steroid catabolic process
|
CYP19A1, CYP1A2, CYP3A4 |
2.30778 |
[BP] GO:0050926 |
None
|
F3, KDR, SMAD3 |
2.30778 |
[BP] GO:1903393 |
None
|
KDR, SMAD3, TEK |
2.30778 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, HMGCR |
2.30355 |
[BP] GO:0007416 |
None
|
ACHE, APP, DRD1, DRD2 |
2.28099 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, ALPL, APP, AXL, CDC25B, CYP1A1, DRD1, DRD2, EGFR, ESR1, FABP4, FLT3, FUT7, HMGCR, KDR, MET, MMP2, MMP9, RORC, SMAD3, SRC, TEK |
2.26494 |
[BP] GO:0021853 |
None
|
DRD1, DRD2 |
2.25571 |
[BP] GO:0046541 |
None
|
CHRM1, CHRM3 |
2.25571 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.25571 |
[BP] GO:0090325 |
None
|
DRD2, DRD3 |
2.25571 |
[BP] GO:1904936 |
None
|
DRD1, DRD2 |
2.25571 |
[BP] GO:0051122 |
hepoxilin biosynthetic process
|
ALOX12, ALOX15 |
2.25571 |
[BP] GO:0051121 |
hepoxilin metabolic process
|
ALOX12, ALOX15 |
2.25571 |
[BP] GO:0042321 |
None
|
ADORA1, DRD2 |
2.25571 |
[BP] GO:0007623 |
circadian rhythm
|
DRD2, DRD3, EGFR, PPARA, RORC |
2.25333 |
[BP] GO:0030155 |
regulation of cell adhesion
|
ALOX12, ALOX15, CYP1B1, DUSP3, KDR, NUAK1, PPARA, SMAD3, SRC, TEK |
2.25232 |
[BP] GO:0007189 |
None
|
DRD1, DRD2, DRD3, DRD5 |
2.24855 |
[BP] GO:0051094 |
positive regulation of developmental process
|
ALOX12, APP, AXL, CA2, CYP1B1, DRD2, F3, HMGCR, INSR, KDR, PIM1, SMAD3, SRC, TEK |
2.2446 |
[BP] GO:0030100 |
regulation of endocytosis
|
ALOX15, APP, AXL, DRD2, PTPN1, SRC |
2.23989 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, CA2, EGFR, FLT3, NR3C1, SRC |
2.23989 |
[BP] GO:0042417 |
None
|
DRD1, DRD2, DRD3 |
2.232 |
[BP] GO:0008209 |
androgen metabolic process
|
CYP19A1, CYP3A4, ESR1 |
2.232 |
[BP] GO:0010605 |
negative regulation of macromolecule metabolic process
|
APP, AURKB, CSNK2A1, DRD3, DUSP3, EGFR, ESR1, ESR2, FABP4, HMGCR, HSPA1A, IGF1R, KDR, MMP9, NR3C1, PPARA, PTPN1, RORC, SMAD3, SRC, TRPV1, XDH |
2.22309 |
[BP] GO:0001775 |
cell activation
|
ALOX5, APP, AXL, EGFR, FLT3, FUT7, HSPA1A, MMP9, RORC, SMAD3, SRC, TRPV1 |
2.21909 |
[BP] GO:0033674 |
positive regulation of kinase activity
|
ADORA1, CDC25B, DRD2, EGFR, FLT3, INSR, PTPN1, SRC, TEK |
2.21903 |
[BP] GO:0071383 |
None
|
EGFR, FLT3, NR3C1, SRC |
2.21013 |
[BP] GO:0048609 |
multicellular organismal reproductive process
|
AKR1B1, APP, AXL, CYP1A1, DRD1, DRD5, EGFR, ESR1, SRC |
2.20887 |
[BP] GO:0030534 |
None
|
APP, DRD1, DRD2, DRD3, PPARA |
2.20558 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADORA1, DRD2, DRD3, GPR35, MMP9 |
2.19346 |
[BP] GO:0019098 |
None
|
APP, DRD1, DRD5 |
2.19346 |
[BP] GO:0032413 |
None
|
DRD2, DRD3, GPR35, MMP9 |
2.19266 |
[BP] GO:0031334 |
positive regulation of protein complex assembly
|
ALOX15, ESR1, HSPA1A, MET, MMP1, SRC |
2.18716 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
ADORA1, AURKB, CDC25B, DRD2, EGFR, FLT3, INSR, PTPN1, SRC, TEK |
2.18434 |
[BP] GO:0070201 |
None
|
ACHE, APP, CHRM1, DRD2, DRD3, EGFR, HCAR2, HMGCR, PTPN1, SMAD3, SRC |
2.18262 |
[BP] GO:0051952 |
None
|
ADORA1, DRD1, DRD2, DRD3 |
2.17544 |
[BP] GO:0031100 |
animal organ regeneration
|
AXL, CSNK2A1, EGFR, FLT3 |
2.17544 |
[BP] GO:0032845 |
None
|
ADORA1, DRD2, HMGCR, SRC, TRPV1 |
2.15898 |
[BP] GO:1901661 |
None
|
AKR1B1, AKR1B10, HMGCR |
2.15898 |
[BP] GO:0043552 |
positive regulation of phosphatidylinositol 3-kinase activity
|
FLT3, SRC, TEK |
2.15898 |
[BP] GO:0042743 |
hydrogen peroxide metabolic process
|
CYP1A1, CYP1A2, EGFR |
2.15898 |
[BP] GO:0046717 |
None
|
CHRM5, DRD2, DRD3, TRPV1 |
2.15848 |
[BP] GO:0016477 |
cell migration
|
AXL, CYP1B1, DRD1, DRD2, EGFR, FUT7, KDR, MMP1, MMP9, SRC, TEK |
2.14119 |
[BP] GO:0030518 |
intracellular steroid hormone receptor signaling pathway
|
ESR1, ESR2, NR3C1, SRC |
2.14011 |
[BP] GO:0018958 |
None
|
AKR1B1, DRD1, DRD2, DRD3 |
2.14011 |
[BP] GO:0050730 |
None
|
ADORA1, APP, EGFR, FLT3, PTPN1, SRC |
2.13853 |
[BP] GO:0006811 |
None
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, CHRM5, DRD1, DRD2, DRD3, FABP3, PPARA, TRPV1 |
2.13004 |
[BP] GO:0051262 |
protein tetramerization
|
ACHE, HMGCR, IGF1R, INSR, TRPV1 |
2.12744 |
[BP] GO:0042220 |
None
|
DRD2, DRD3, DRD5 |
2.12744 |
[BP] GO:1901890 |
None
|
KDR, SMAD3, TEK |
2.12744 |
[BP] GO:0071276 |
cellular response to cadmium ion
|
CYP1A2, EGFR, MMP9 |
2.12744 |
[BP] GO:0045744 |
None
|
DRD2, DRD3, MET |
2.12744 |
[BP] GO:0006691 |
None
|
ALOX12, ALOX15, ALOX5 |
2.12744 |
[BP] GO:0021843 |
None
|
DRD1, DRD2 |
2.12442 |
[BP] GO:1990535 |
None
|
APP, INSR |
2.12442 |
[BP] GO:0021830 |
None
|
DRD1, DRD2 |
2.12442 |
[BP] GO:0002933 |
lipid hydroxylation
|
CYP1A1, CYP3A4 |
2.12442 |
[BP] GO:0021826 |
None
|
DRD1, DRD2 |
2.12442 |
[BP] GO:0046958 |
None
|
DRD1, DRD5 |
2.12442 |
[BP] GO:1900542 |
None
|
DRD1, DRD2, DRD3, DRD5, INSR, PPARA |
2.12281 |
[BP] GO:0048731 |
system development
|
ACHE, ADORA1, ALPL, CHRM1, CHRM2, CHRM3, MMP9, SMAD3, SRC, TEK |
2.12119 |
[BP] GO:0019932 |
second-messenger-mediated signaling
|
DRD1, DRD2, DRD3, DRD5, EGFR, KDR |
2.11548 |
[BP] GO:0006464 |
cellular protein modification process
|
ALPL, APP, AURKB, AXL, CDC25B, CHRM1, CHRM3, CSNK2A1, DRD1, DUSP3, EGFR, ESR1, FLT3, FUT7, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTPN1, SMAD3, SRC, TEK |
2.11548 |
[BP] GO:0036211 |
protein modification process
|
ALPL, APP, AURKB, AXL, CDC25B, CHRM1, CHRM3, CSNK2A1, DRD1, DUSP3, EGFR, ESR1, FLT3, FUT7, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PTPN1, SMAD3, SRC, TEK |
2.11548 |
[BP] GO:0035303 |
None
|
ADORA1, CHRM5, DRD2, NUAK1, SMAD3 |
2.11548 |
[BP] GO:0043412 |
macromolecule modification
|
ALPL, APP, AURKB, AXL, CDC25B, CHRM1, CHRM3, CSNK2A1, DRD1, DUSP3, EGFR, ESR1, FLT3, FUT7, IGF1R, INSR, KDR, MET, NR3C1, NUAK1, PIM1, PTPN1, SMAD3, SRC, TEK |
2.11129 |
[BP] GO:2000116 |
regulation of cysteine-type endopeptidase activity
|
CSNK2A1, F3, MMP9, SMAD3, SRC, XDH |
2.10838 |
[BP] GO:0022029 |
None
|
DRD1, DRD2, EGFR |
2.10258 |
[BP] GO:0098801 |
None
|
ADORA1, DRD2, DRD3 |
2.10258 |
[BP] GO:1901655 |
None
|
AKR1B1, EGFR, NR3C1, SRC |
2.10173 |
[BP] GO:0002791 |
None
|
ACHE, ADORA1, DRD2, DRD3, EGFR, HCAR2, HMGCR, SRC |
2.10074 |
[BP] GO:0010557 |
positive regulation of macromolecule biosynthetic process
|
APP, AURKB, DRD2, DRD3, EGFR, ESR1, ESR2, IGF1R, INSR, KDR, MET, NR3C1, PPARA, RORC, SMAD3, SRC |
2.10038 |
[BP] GO:0009653 |
anatomical structure morphogenesis
|
APP, AXL, CA2, CA9, CYP1B1, DRD2, EGFR, ESR1, INSR, MET, MMP2, SMAD3, SRC, TEK |
2.09379 |
[BP] GO:1903426 |
None
|
EGFR, INSR, SMAD3, TRPV1 |
2.08507 |
[BP] GO:1901888 |
regulation of cell junction assembly
|
KDR, SMAD3, SRC, TEK |
2.08507 |
[BP] GO:0006140 |
None
|
DRD1, DRD2, DRD3, DRD5, INSR, PPARA |
2.07007 |
[BP] GO:0090218 |
positive regulation of lipid kinase activity
|
FLT3, SRC, TEK |
2.07007 |
[BP] GO:0010907 |
None
|
INSR, PPARA, SRC |
2.07007 |
[BP] GO:0106027 |
None
|
APP, IGF1R, INSR |
2.07007 |
[BP] GO:0032410 |
None
|
DRD2, DRD3, GPR35, MMP9 |
2.06941 |
[BP] GO:1904063 |
None
|
DRD2, DRD3, GPR35, MMP9 |
2.06941 |
[BP] GO:0045766 |
positive regulation of angiogenesis
|
ALOX12, CYP1B1, F3, KDR, TEK |
2.06438 |
[BP] GO:0048167 |
None
|
ADORA1, APP, DRD1, DRD2, DRD5 |
2.06438 |
[BP] GO:0010564 |
regulation of cell cycle process
|
APP, AURKB, CDC25B, CSNK2A1, CYP1A1, DRD2, DRD3, EGFR, HSPA1A, INSR |
2.06208 |
[BP] GO:0031960 |
response to corticosteroid
|
ALPL, EGFR, FLT3, NR3C1, SRC |
2.0532 |
[BP] GO:0051781 |
None
|
AURKB, CDC25B, DRD2, DRD3 |
2.0532 |
[BP] GO:0071868 |
None
|
APP, DRD1, DRD5 |
2.0387 |
[BP] GO:0071870 |
None
|
APP, DRD1, DRD5 |
2.0387 |
[BP] GO:0045936 |
None
|
DRD2, DRD3, DUSP3, FABP4, HMGCR, IGF1R, PPARA, PTPN1, XDH |
2.02413 |
[BP] GO:0010563 |
None
|
DRD2, DRD3, DUSP3, FABP4, HMGCR, IGF1R, PPARA, PTPN1, XDH |
2.01957 |
[BP] GO:0042058 |
None
|
ADORA1, APP, EGFR, MMP9 |
2.01957 |
[BP] GO:0040011 |
locomotion
|
AXL, CYP1B1, DRD1, DRD2, EGFR, FUT7, KDR, MET, MMP1, MMP9, SRC, TEK |
2.01957 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2D6 |
2.01246 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2D6 |
2.01246 |
[BP] GO:0032880 |
regulation of protein localization
|
ACHE, APP, CHRM1, CSNK2A1, DRD2, DRD3, EGFR, HCAR2, HMGCR, PTPN1, SMAD3, SRC |
2.00907 |
[BP] GO:0051046 |
None
|
ACHE, ADORA1, CYP19A1, DRD2, DRD3, EGFR, HCAR2, HMGCR, SRC, TRPV1 |
2.00411 |
[BP] GO:0051336 |
regulation of hydrolase activity
|
APP, CSNK2A1, DRD2, EGFR, ESR1, F3, HSPA1A, MMP9, NUAK1, PTPN1, SMAD3, SRC, XDH |
2.00411 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
ESR1, ESR2, NR3C1, PPARA, RORC |
2.00324 |
[BP] GO:0048729 |
tissue morphogenesis
|
CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
2.00017 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ALOX12, ALOX15, ALPL, APP, AXL, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, F3, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, MET, MMP2, PIM1, PTPN1, SMAD3, SRC, TEK, TRPV1 |
6.36467 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, APP, AXL, CA4, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, TEK, TRPV1 |
5.98959 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA1, ADORA3, ALOX15, APP, AXL, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, SRC, TEK, TRPV1 |
5.19368 |
[CC] GO:0098590 |
plasma membrane region
|
ADORA1, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD5, EGFR, INSR, MET, SRC, TEK, TRPV1 |
5.17623 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, APP, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5, FLT3, GPR35, IGF1R, INSR, KDR, MET, TEK, TRPV1 |
5.07011 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ALOX12, ALOX15, ALOX5, ALPL, APP, AXL, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, F3, FLT3, FUT7, GPR35, HCAR2, HMGCR, HSD11B1, IGF1R, INSR, KDR, MET, MMP2, PIM1, PTPN1, SMAD3, SRC, TEK, TRPV1 |
4.35515 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA1, ADORA3, ALOX15, ALPL, APP, AXL, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, F3, FLT3, FUT7, GPR35, HCAR2, HMGCR, HSD11B1, IGF1R, INSR, KDR, MET, PTPN1, SRC, TEK, TRPV1 |
4.09672 |
[CC] GO:0031253 |
None
|
ADORA1, CA4, CA9, DRD1, DRD2, DRD5, INSR, SRC, TRPV1 |
3.78133 |
[CC] GO:0016323 |
basolateral plasma membrane
|
ADORA1, CA2, CA4, CA9, CHRM3, EGFR, TEK |
3.44791 |
[CC] GO:0044463 |
None
|
ADORA1, AKR1B1, APP, CA4, CA9, CHRM1, CHRM2, CHRM3, DRD1, DRD2, DRD5, INSR, SRC, TRPV1 |
2.93396 |
[CC] GO:0120038 |
None
|
ADORA1, AKR1B1, APP, CA4, CA9, CHRM1, CHRM2, CHRM3, DRD1, DRD2, DRD5, INSR, SRC, TRPV1 |
2.93396 |
[CC] GO:0098793 |
None
|
ADORA1, APP, CHRM1, CHRM2, CHRM3, DRD2 |
2.77889 |
[CC] GO:0045202 |
None
|
ACHE, APP, CHRM1, CHRM2, CHRM3, CHRM5, EGFR |
2.66295 |
[CC] GO:0043679 |
None
|
CHRM1, CHRM2, CHRM3, DRD2 |
2.61636 |
[CC] GO:0031224 |
None
|
ACHE, ADORA1, ADORA3, ALPL, APP, AXL, CA12, CA14, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, CYP3A4, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, F3, FLT3, FUT7, GPR35, HCAR2, HMGCR, HSD11B1, IGF1R, INSR, KDR, MET, TEK, TRPV1 |
2.33728 |
[CC] GO:0044306 |
None
|
CHRM1, CHRM2, CHRM3, DRD2 |
2.28099 |
[CC] GO:0044456 |
None
|
ACHE, ADORA1, APP, CHRM1, CHRM2, CHRM3, CHRM5, DRD2, SRC, TRPV1 |
2.14259 |
[CC] GO:0097443 |
sorting endosome
|
KDR, PTPN1 |
2.12442 |
[CC] GO:0097730 |
None
|
DRD1, DRD2, DRD5 |
2.10258 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, APP, AURKB, CA1, CA2, CA4, CA7, CDC25B, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, FABP3, FABP4, FDPS, FLT3, FUT7, HMGCR, HSD11B1, HSD17B1, HSPA1A, INSR, KDR, MMP2, MMP9, NR3C1, PIM1, PTPN1, SMAD3, SRC, TRPV1, XDH |
2.03764 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX12, ALOX15, ALOX5, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, ESR1, ESR2, MMP1, MMP2, MMP9, NR3C1, PIM1, PPARA, PTPN1, RORC, SMAD3, XDH |
12.7094 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX12, ALOX15, ALOX5, ALPL, APP, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, F3, FABP3, FABP4, FDPS, FLT3, HMGCR, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NR3C1, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TRPV1, XDH |
12.4208 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CHRM1, CHRM2, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, DRD5, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, PPARA, SRC, TEK, TRPV1 |
10.083 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
10.083 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, F3, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, MET, NR3C1, PPARA, RORC, TEK, TRPV1 |
9.96296 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDC25B, CHRM1, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DUSP3, EGFR, F3, FDPS, FLT3, FUT7, HMGCR, HSD11B1, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PIM1, PTPN1, SRC, TEK, XDH |
9.6136 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, F3, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, MET, NR3C1, PPARA, RORC, TEK, TRPV1 |
8.9956 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, F3, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, MET, NR3C1, PPARA, RORC, SMAD3, TEK, TRPV1 |
8.86227 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, F3, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, MET, NR3C1, PPARA, RORC, TEK, TRPV1 |
8.73132 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
7.47638 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX12, ALOX15, ALOX5, ALPL, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CHRM3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, DRD5, ESR1, ESR2, FDPS, MMP1, MMP2, MMP9, NR3C1, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, TRPV1, XDH |
7.32576 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4 |
7.10634 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5, EGFR, F3, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, MET, TEK, TRPV1 |
7.07987 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5, EGFR, F3, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, MET, TEK, TRPV1 |
7.07987 |
[MF] GO:0005506 |
iron ion binding
|
ALOX12, ALOX15, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, XDH |
6.97795 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4 |
6.84712 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
6.84712 |
[MF] GO:0016907 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
6.59698 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.50497 |
[MF] GO:0030594 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5 |
5.91893 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
5.72155 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4 |
5.62688 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
5.53849 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, CA9, ESR1, ESR2, MMP1, MMP2, MMP9, NR3C1, PPARA, PTPN1, RORC, SMAD3 |
5.46221 |
[MF] GO:0042562 |
hormone binding
|
ACHE, CHRM3, EGFR, HSD17B1, IGF1R, INSR, NR3C1 |
5.43333 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, HMGCR, HSD11B1, HSD17B1, XDH |
5.26175 |
[MF] GO:0004952 |
None
|
DRD1, DRD2, DRD3, DRD5 |
4.97945 |
[MF] GO:0035240 |
None
|
DRD1, DRD2, DRD3, DRD5 |
4.83516 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, CHRM3, DRD1, DRD2, DRD3, DRD5 |
4.522 |
[MF] GO:0046872 |
metal ion binding
|
ALOX12, ALOX15, ALOX5, ALPL, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, ESR1, ESR2, FDPS, MMP1, MMP2, MMP9, NR3C1, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, TRPV1, XDH |
4.41855 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, SRC |
4.35995 |
[MF] GO:0015464 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
4.28878 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
4.27516 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, SRC |
4.17693 |
[MF] GO:0005496 |
steroid binding
|
CYP3A4, ESR1, ESR2, HSD17B1, NR3C1, RORC |
4.16717 |
[MF] GO:0008289 |
lipid binding
|
ALOX15, AXL, CYP3A4, ESR1, ESR2, F3, FABP3, FABP4, HSD17B1, NR3C1, PPARA, RORC, TRPV1 |
4.1368 |
[MF] GO:1901338 |
None
|
DRD1, DRD2, DRD3, DRD5 |
4.13378 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4 |
3.94469 |
[MF] GO:0008227 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, DRD2 |
3.76936 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, NR3C1, PPARA, RORC |
3.707 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
3.52513 |
[MF] GO:0016725 |
oxidoreductase activity, acting on CH or CH2 groups
|
CYP1A2, CYP3A4, XDH |
3.523 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, INSR, KDR |
3.523 |
[MF] GO:0004629 |
None
|
ADORA1, CHRM1, CHRM3, CHRM5 |
3.50333 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
3.47568 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2D6, CYP3A4 |
3.31528 |
[MF] GO:0048037 |
cofactor binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, HMGCR, HSD17B1, SRC, XDH |
3.23134 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MMP9, PIM1, PPARA, PTPN1, SMAD3, SRC |
3.1975 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, HMGCR, HSD11B1, HSD17B1, XDH |
3.18358 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
3.17703 |
[MF] GO:0099528 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
3.14877 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
3.07766 |
[MF] GO:0047977 |
hepoxilin-epoxide hydrolase activity
|
ALOX12, ALOX15 |
3.07766 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4 |
2.92409 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, EGFR, FLT3, IGF1R, INSR, KDR, MMP9, PPARA, PTPN1, SMAD3, SRC |
2.86869 |
[MF] GO:0019902 |
phosphatase binding
|
EGFR, HMGCR, MET, PPARA, PTPN1, SMAD3 |
2.80338 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, PPARA, RORC |
2.77979 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, PPARA, RORC |
2.77979 |
[MF] GO:0031072 |
heat shock protein binding
|
ADORA1, CSNK2A1, HSPA1A, KDR, NR3C1 |
2.68206 |
[MF] GO:0070576 |
vitamin D 24-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.67856 |
[MF] GO:0004052 |
arachidonate 12-lipoxygenase activity
|
ALOX12, ALOX15 |
2.67856 |
[MF] GO:0051120 |
hepoxilin A3 synthase activity
|
ALOX12, ALOX15 |
2.67856 |
[MF] GO:0042578 |
None
|
ADORA1, ALPL, CDC25B, CHRM1, CHRM3, CHRM5, DUSP3, PTPN1 |
2.59206 |
[MF] GO:0019899 |
enzyme binding
|
APP, AURKB, CDC25B, CYP1A1, CYP1A2, CYP3A4, DUSP3, EGFR, ESR1, ESR2, F3, HMGCR, HSPA1A, MET, NR3C1, PPARA, PTPN1, SMAD3, SRC, TEK |
2.55397 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK |
2.54886 |
[MF] GO:0004930 |
None
|
ADORA1, ADORA3, CHRM1, CHRM2, CHRM3, CHRM5, DRD1, DRD2, DRD3, DRD5, GPR35, HCAR2 |
2.53578 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, HMGCR, HSD11B1, HSD17B1 |
2.46597 |
[MF] GO:0043168 |
anion binding
|
ALOX15, APP, AURKB, AXL, CSNK2A1, EGFR, F3, FABP3, FABP4, FLT3, HMGCR, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TRPV1, XDH |
2.45143 |
[MF] GO:0016788 |
None
|
ACHE, ADORA1, ALPL, CA1, CA2, CDC25B, CHRM1, CHRM3, CHRM5, DUSP3, PTPN1 |
2.45143 |
[MF] GO:0097159 |
organic cyclic compound binding
|
ADORA1, APP, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, FDPS, FLT3, HMGCR, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NR3C1, NUAK1, PIM1, PPARA, PTPN1, RORC, SMAD3, SRC, TEK, TRPV1, XDH |
2.43433 |
[MF] GO:0001588 |
None
|
DRD1, DRD5 |
2.43276 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.43276 |
[MF] GO:0034875 |
caffeine oxidase activity
|
CYP1A2, CYP3A4 |
2.43276 |
[MF] GO:0051425 |
None
|
APP, INSR |
2.43276 |
[MF] GO:0033695 |
oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor
|
CYP1A2, CYP3A4 |
2.43276 |
[MF] GO:0036094 |
small molecule binding
|
ADORA1, AURKB, AXL, CSNK2A1, EGFR, FABP3, FABP4, FLT3, HMGCR, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TRPV1, XDH |
2.42882 |
[MF] GO:0019838 |
growth factor binding
|
EGFR, IGF1R, INSR, KDR, TEK |
2.3239 |
[MF] GO:0016702 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen
|
ALOX12, ALOX15, ALOX5 |
2.30778 |
[MF] GO:0004435 |
None
|
CHRM1, CHRM3, CHRM5 |
2.26321 |
[MF] GO:0016701 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen
|
ALOX12, ALOX15, ALOX5 |
2.26321 |
[MF] GO:0101020 |
estrogen 16-alpha-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.25571 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.25571 |
[MF] GO:0043559 |
insulin binding
|
IGF1R, INSR |
2.25571 |
[MF] GO:0043548 |
phosphatidylinositol 3-kinase binding
|
AXL, IGF1R, INSR |
2.19346 |
[MF] GO:0140096 |
catalytic activity, acting on a protein
|
AURKB, AXL, CDC25B, CSNK2A1, DUSP3, EGFR, F3, FLT3, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, PIM1, PTPN1, SRC, TEK |
2.18262 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, APP, CSNK2A1, DRD2, EGFR, ESR1, ESR2, FLT3, HMGCR, IGF1R, KDR, MET, MMP9, SMAD3, TRPV1, XDH |
2.17282 |
[MF] GO:0005158 |
None
|
IGF1R, PTPN1, SRC |
2.12744 |
[MF] GO:0005524 |
ATP binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TRPV1 |
2.126 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.12442 |
[MF] GO:0051879 |
Hsp90 protein binding
|
CSNK2A1, KDR, NR3C1 |
2.10258 |
[MF] GO:0032559 |
adenyl ribonucleotide binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TRPV1 |
2.04465 |
[MF] GO:0030554 |
adenyl nucleotide binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIM1, SRC, TEK, TRPV1 |
2.01957 |
[MF] GO:0005021 |
vascular endothelial growth factor-activated receptor activity
|
FLT3, KDR |
2.01246 |
[MF] GO:0030235 |
nitric-oxide synthase regulator activity
|
EGFR, ESR1 |
2.01246 |
[MF] GO:0001609 |
None
|
ADORA1, ADORA3 |
2.01246 |